David Hallal

David L.
Hallal is the founder of ElevateBio LLC, founded in 2017, where the title held is Executive Chairman.
Current jobs include Chairman & Chief Executive Officer at Scholar Rock Holding Corp.
since 2025; Chairman at iTeos Therapeutics SA since 2018; Chairman at Scholar Rock, Inc. since 2017; Independent Chairman at Kalaris Therapeutics, Inc. since 2025; Director at Pharmaceutical Research & Manufacturers of America; and Director at LifeEDIT Therapeutics, Inc. Former jobs include Chief Executive Officer & Director at Alexion Pharmaceuticals, Inc. from 2015 to 2016; Chairman & Chief Executive Officer at AlloVir, Inc. from 2018 to 2021; Chairman at iTeos Therapeutics, Inc. from 2018 to 2025; Director-Southeast Oncology Sales at Amgen, Inc. from 1992 to 2002; Director-National Sales at Oldtech, Inc.; Lead Independent Director at Seer, Inc. (California) from 2020 to 2024; Head-Sales at Biogen, Inc. from 2002 to 2004; and Vice President-Sales at (OSI) Eyetech from 2004 to 2006.
Education includes undergraduate studies at the University of New Hampshire.